The next step, which major pharmaceutical companies are currently working hard to develop, are receptor subtype-specific drugs and other specific agents.
He saw the oblivious subtype as being grandiose, arrogant, and thick-skinned, and the hypervigilant subtype as being easily hurt, oversensitive, and ashamed.